Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation

References

• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Delivery Rev 2009; 61: 428–37
   PubMed Web of Science ®Google Scholar
• Allémann E, Gurny R, Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process, influence of process parameters on particles size. Int J Pharm 1992; 87: 247–53
   Web of Science ®Google Scholar
• Apers S, Naessens T, Pieters L, Vlietinck A. Densitometric thin-layer chromatographic determination of aescin in a herbal medicinal product containing Aesculus and Vitis dry extracts. J Chromatogr A 2006; 1112: 165–70
   PubMed Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 2005; 24: 67–75
   PubMed Web of Science ®Google Scholar
• Blanco MD, Alonso MJ. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm 1997; 43: 287–94
   Web of Science ®Google Scholar
• Breunig M, Bauer S, Goepferich A. Polymers and nanoparticles: Intelligent tools for intracellular targeting. Eur J Pharm Biopharm 2008; 68: 112–28
   PubMed Web of Science ®Google Scholar
• Briones E, Colino CI, Lanao JM. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Controlled Release 2008; 125: 210–27
   PubMed Web of Science ®Google Scholar
• Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control. Nat Rev Microbiol 2007; 5: S7–S16
   Web of Science ®Google Scholar
• Chellat F, Merhi Y, Moreau A, Yahia L. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005; 26: 7260–75
   PubMed Web of Science ®Google Scholar
• Clift MJD, Rothen-Rutishauser B, Brown DM, Duffin R, Donaldson K, Proudfoot L, Guy K, Stone V. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol 2008; 232: 418–27
   PubMed Web of Science ®Google Scholar
• Cohen-Sela E, Teitlboim S, Chorny M, Koroukhov N, Danenberg HD, Gao J, Golomb G. Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: Formulations of mithramycin and bioactivity. J Pharm Sci 2009; 98(4)1452–62
   PubMed Web of Science ®Google Scholar
• Date AA, Joshi MD, Patravale VB. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Delivery Rev 2007; 59: 505–21
   PubMed Web of Science ®Google Scholar
• Delmas F, Di Giorgio C, Elias R, Gasquet M, Azas N, Mshvildadze V, Dekanosidze G, Kemertelidze E, Timon-David P. Antileishmanial activity of three saponins isolated from ivy, α-hederin, β-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro. Planta Med 2000; 66: 343–7
   PubMed Web of Science ®Google Scholar
• DNDi. 2008. 2007–2008 Annual report, Drugs for neglected diseases initiative, Geneva, Switzerland
   Google Scholar
• Dutta A, Ghoshal A, Mandal D, Mondal NB, Banerjee S, Sahu NP, Mandal C. Racemoside A. An anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani. J Med Microbiol 2007; 56: 1196–204
   PubMed Web of Science ®Google Scholar
• Frézard F, Demicheli C. New delivery strategies for the old pentavalent antimonial drugs. Expert Opin Drug Deliv 2010; 7(12)1343–58
   PubMed Web of Science ®Google Scholar
• Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 2004; 21(8)1428–1439
   PubMed Web of Science ®Google Scholar
• Han K, Lee K-D, Gao Z-G, Park J-S. Preparation and evaluation of poly(L-lactic acid) microspheres containing rhEGF for chronic gastric ulcer healing. J Controlled Release 2001; 75: 259–69
   PubMed Web of Science ®Google Scholar
• Herrmann J, Bodmeier R. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. Eur J Pharm Biopharm 1998; 45: 75–82
   PubMed Web of Science ®Google Scholar
• Holzer M, Vogel V, Mäntele W, Schwartz D, Haase W, Langer K. Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage. Eur J Pharm Biopharm 2009; 72: 428–37
   PubMed Web of Science ®Google Scholar
• Italia JL, Yahya MM, Singh D, Ravi Kumar MNV. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone®. Pharm Res 2009; 26(6)1324–31
   PubMed Web of Science ®Google Scholar
• Kedzierski L, Sakthianandeswaren A, Curtis JM, Andrews PC, Junk PC, Kedzierska K. Leishmaniasis: Current treatment and prospects for new drugs and vaccines. Curr Med Chem 2009; 16: 599–614
   PubMed Web of Science ®Google Scholar
• Konan YN, Gurny R, Allémann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm 2002; 233: 239–52
   PubMed Web of Science ®Google Scholar
• Le Pape P. Development of new antileishmanial drugs - current knowledge and future prospects. J Enzyme Inhib Med Chem 2008; 23(5)708–18
   PubMed Web of Science ®Google Scholar
• Lewis GA, Mathieu D, Phan-Tan-Luu R. Pharmaceutical experimental design. Marcel Dekker, New YorkUSA 1999
   Google Scholar
• Maes L, Vanden Berghe D, Germonprez N, Quirijnen L, Cos P, De Kimpe N, Van Puyvelde L. In vitro and in vivo activity of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species. Antimicrob Agents Chemother 2004; 48: 130–6
   PubMed Web of Science ®Google Scholar
• McCarron PA, Donnelly RF, Marouf W. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. J Microencapsulation 2006; 23(5)480–98
   PubMed Web of Science ®Google Scholar
• Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: A review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine 2010; 6(1)9–24
   PubMed Web of Science ®Google Scholar
• Müller RH. Colloidal carriers for controlled drug delivery and targeting: Modification, characterization and in vivo distribution. Wiss Verl-Ges, Stuttgart, Germany 1990
   Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Controlled Release 2008; 125: 193–209
   PubMed Web of Science ®Google Scholar
• Murakami H, Kawashima Y, Niwa T, Hino T, Takeuchi H, Kobayashi M. Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(DL-lactide-co-glycolide) nanoparticles. Int J Pharm 1997; 149: 43–9
   Web of Science ®Google Scholar
• Nagayama S, Ogawara K, Fukuoka Y, Higaki K, Kimura T. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm 2007; 342: 215–21
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Delivery Rev 2003; 55: 329–47
   PubMed Web of Science ®Google Scholar
• Park TG, Lee HY, Nam YS. A new preparation method for protein loaded poly(D,L-lactic-co-glycolic acid) microspheres and protein release mechanism study. J Controlled Release 1998; 55: 181–91
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998; 24(12): 1113–28
   Google Scholar
• Rawat A, Burgess DJ. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics. Int J Pharm 2010; 394: 99–105
   PubMed Web of Science ®Google Scholar
• Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006; 2: 8–21
   Google Scholar
• Rocha LG, Almeida JRGS, Macêdo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine 2005; 12: 514–35
   PubMed Web of Science ®Google Scholar
• Sheng Y, Liu C, Yuan Y, Tao X, Yang F, Shan X, Zhou H, Xu F. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials 2009; 30: 2340–8
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic “design of experiments”. Part I: Fundamental aspects. Crit Rev Ther Drug Carrier Syst 2004; 22(1): 27–105
   Google Scholar
• Song KC, Lee HS, Choung IY, Cho KI, Ahn Y, Choi EJ. The effect of type of organic phase solvents on the particle size of poly(D,L-lactide-co-glycolide) nanoparticles. Colloids Surf A 2006; 276: 162–7
   Web of Science ®Google Scholar
• Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, Cai Z, Li Y, Chen Q. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 2008b; 69: 445–53
   PubMed Web of Science ®Google Scholar
• Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, Li Y, Hou S. PLGA nanoparticles simultaneously loaded with vincristine sulphate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm 2008a; 350: 320–9
   PubMed Web of Science ®Google Scholar
• Van de Ven H, Vermeersch M, Vandenbroucke RE, Matheeussen A, Apers S, Weyenberg W, De Smedt SC, Cos P, Maes L, Ludwig A. Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles. J Drug Target 2011, doi: 10.3109/1061186X.2011.595491
   PubMedGoogle Scholar
• Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009; 26(5)1025–58
   PubMed Web of Science ®Google Scholar
• Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B, Kipp J, Ning J. Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects. Adv Drug Delivery Rev 2008; 60: 939–54
   PubMed Web of Science ®Google Scholar